If cancer returns, treatment is often to try and stall its growth. Ovarian cancer is a tough foe, but a new trial has found one medication that may help control the disease.

Even after a cancer is successfully treated, there's still a risk that another cancer may show up at some point down the line. A recent Spanish study looked at the risk of second cancers in breast cancer survivors.

Ovarian cancer has been linked to genetics, environment and hormones. But scientists still aren’t totally sure whether diet and sugar may play a role too.

Women with ovarian cancer can have their genes tested for mutations that trigger cancer growth. But certain gene mutations don’t necessarily help or hurt a patient’s chances.

Loads of health problems have been linked to obesity in recent medical studies. Fortunately, ovarian cancer and obesity don't necessarily go hand-in-hand.

Who wants to be given a shot every single day for a month after surgery just to prevent the chance of developing a blood clot? People who really don’t want to get blood clots—that’s who.

What if the odds of beating ovarian cancer could be improved by tinkering with existing chemotherapies? Tweaking chemo regimens may help patients who become resistant to initial therapies.

What if a blood test could flag a greater risk for ovarian cancer? Testing for blood calcium levels is a pretty simple process and may someday be a helpful tool in diagnosing ovarian cancer. 

A major risk factor for breast cancer is carrying a harmful mutation in the BRCA1 or BRCA2 genes. Finding out whether or not a BRCA gene alteration is harmful hasn’t been all that easy, though. That could be changing.

Cancer outcomes are not black and white. There are constantly shifting variables that can change the course of disease. Scientists have scratched beneath the surface of shifts in ovarian cancer cells.